“Our mission is to provide novel therapeutics for malignant and non-malignant hematologic disorders through the application of our proprietary technology and innovative chemistries.”
HemaQuest Pharmaceuticals is a San Diego and Seattle-based biopharmaceutical company focused on developing small molecule therapeutics based on its short chain fatty acid (SCFA) derivative technologies to treat serious and life-threatening orphan hematologic disorders, including sickle cell disease and beta thalassemia as well as viral-related malignancies. The Company currently has one product in clinical development, HQK-1001 for treating sickle cell disease and beta thalassemia.
We offer competitive salaries, benefits, stock options, and the opportunity and challenge of a company in early clinical trials with further development of its pipeline underway in a first-class environment. We are looking for highly motivated, bright, and committed individuals to join our team. If you would like to be considered for positions at HemaQuest, please submit your resume by email to: firstname.lastname@example.org.
UNSECURED E-MAIL WARNING: This link allows you to send unsecured email to HemaQuest. Due to the nature of the Internet, there is a possibility that unsecured (unencrypted) email could be intercepted and read by third parties. HemaQuest assumes no responsibility for interception of confidential information you send in an unsecured (unencrypted) email message. You may review our Resume Policy here.
Resumes and cover letters may also be sent to:
HemaQuest Pharmaceuticals, Inc.
11995 El Camino Real, Suite 302
San Diego, CA 92130
Phone: (858) 356-5590
Fax: (858) 356-5579
HemaQuest Pharmaceuticals, Inc. is an Equal Opportunity Employer.